Ethiopia Malaria Resurgence in 2024
Ethiopia recorded more than 10 million malaria cases in 2024, marking a severe surge compared to fewer than one million cases in 2019, according to data from the World Health Organization and scientific research published in PMC. The dramatic increase coincides with climatic variability, population displacement, and disruptions to essential health services and vector-control interventions.
Rapid Spread of Drug and Diagnostic Resistance
A cross-sectional survey conducted by the Ethiopian Public Health Institute between July and August 2024 across 20 sentinel sites in 11 regions revealed widespread genetic mutations among parasites. Researchers analyzed 2,204 patients with symptomatic, microscopy-positive malaria and found that Plasmodium falciparum parasites carried mutations associated with partial resistance to artemisinin-based combination therapies. Specifically, the pfk13 gene mutation R622I appeared in 35.5 percent of sequenced samples, alongside other validated resistance markers.
Diagnostic Escape Mutations Hinder Detection
The survey also identified significant deletions in the pfhrp2 and pfhrp3 genes among parasites in Ethiopia. These deletions allow Plasmodium falciparum to evade detection by widely used histidine-rich protein 2-based rapid diagnostic tests, causing false-negative results that delay critical medical care. The findings validate Ethiopia’s 2002 [sic: 2022] decision to transition toward alternative diagnostic tools that do not depend exclusively on HRP2 protein detection.
Mankush Health Centre Data Preceding Reservoir Filling
Research from the Mankush Health Centre in the Guba district documented a high baseline malaria burden in the Benishangul-Gumuz region before the filling of the Grand Ethiopian Renaissance Dam reservoir began. Between 2014 and 2018, clinic records showed that 8,658 patients tested positive out of 16,964 suspected cases tested during an influx of seasonal agricultural workers. Positivity rates dropped from approximately 85 percent in 2014 to 35 percent in 2018, demonstrating an established local transmission cycle independent of subsequent reservoir filling activities that started in July 2020.
Frequently Asked Questions About the Ethiopian Malaria Outbreak
What specific diagnostic failures are doctors encountering in Ethiopia?
Parasites carrying pfhrp2/3 gene deletions evade standard rapid diagnostic tests that rely on histidine-rich protein detection, resulting in false negatives. The Ethiopian Public Health Institute documented these diagnostic-escape mutations during its 2024 surveillance across 11 regions.
How many malaria cases and deaths did the World Health Organization model for Ethiopia in 2024?
The World Health Organization country profile, utilizing the World Malaria Report 2025, estimates approximately 12.4 million malaria cases and 22,400 deaths in Ethiopia for 2024, with uncertainty models ranging between 6.9 and 18.6 million cases.
Which antimalarial drug resistance markers were identified in the 2024 survey?
Sequencing data from the Ethiopian Public Health Institute survey confirmed World Health Organization-validated artemisinin resistance mutations in the pfk13 gene, including R622I at a 35.5 percent prevalence, alongside mutations in pfmdr1, pfdhfr, pfdhps, and pfcrt genes.
Worth a look